VVOS (VVOS) Stock Price & Analysis
VVOS (VVOS) rose 6.76% to USD 0.19 as of September 8, 2026 at 07:37 UTC, according to Nexqual real-time market data.
VVOS last closed at USD 0.19; the session ranged USD 0.16–0.19 on volume of 4,503,850 shares. Market capitalization is —, with a 52-week range of USD 0.16–4.02 (NCM). Source: Nexqual, September 8, 2026 at 07:37 UTC.
Key Statistics (as of September 8, 2026 at 07:37 UTC)
| Price | USD 0.19 |
|---|---|
| Change | ▲ 6.76% (up) |
| Previous Close | USD 0.19 |
| Open | USD 0.19 |
| Day Range | USD 0.16 – 0.19 |
| 52-Week Range | USD 0.16 – 4.02 |
| Volume | 4,503,850 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (VVOS)
Nexqual's technical model rates VVOS "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 07:37 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 28.88 (oversold) |
| vs SMA50 | Below (USD 0.36) |
| MACD | -0.06 (negative) |
From VVOS's Latest SEC 10-K Filing (filed 2026-04-15)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ABVC | ABVC Biopharma, Inc. | USD 0.96 | ▲ 10.98% |
| VRPX | Virpax Pharmaceuticals, Inc. | USD 0 | ▲ 0% |
| RNAZ | TransCode Therapeutics, Inc. | USD 2.06 | ▲ 2.49% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.46 | ▲ 2.93% |
| TPST | Tempest Therapeutics, Inc. | USD 1.03 | ▼ 6.36% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:37 UTC. This page is informational and not investment advice.